Avneet Vig
Rheumatology · Miami, FLNPI 1750672200
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,338 of the $2,933 with a category attached, or 79.7%. 14 manufacturers reported payments, led by Johnson & Johnson at 30.7% of the total. Reporting peaked in 2022 at $1,128 and has fallen 97.9% since, to $24 in 2025. That places this record below the midpoint for rheumatology clinicians in FL, where the typical reported total is $6,335.
Across 147 payments — averaging $19.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$900
- GSK$571
- AbbVie$434
- Amgen$310
- Radius Health, Inc.$162
- Aurinia Pharma U.S., Inc.$146
- plus $409 from 8 others
Across 6 payments — averaging $1778.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$11K
What the payments were for
- Consulting fees$35512%
- Grants$2408%
- Food & beverage$2,33880%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 77 | $900 |
| GSK | 13 | $571 |
| AbbVie | 9 | $434 |
| Amgen(2 entities) | 15 | $310 |
| Radius Health, Inc. | 8 | $162 |
| Aurinia Pharma U.S., Inc. | 7 | $146 |
| UCB, Inc. | 4 | $107 |
| Lilly USA, LLC | 4 | $82 |
| Organon | 3 | $62 |
| Novartis | 2 | $50 |
| E.r. Squibb & Sons, L.L.C. | 2 | $35 |
| Mallinckrodt Hospital Products Inc. | 1 | $34 |
| Fidia Pharma USA Inc. | 1 | $24 |
| AstraZeneca | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,933 in reported general payments places this provider in the 35th percentile of 453 rheumatology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MethotrexateMethotrexate Sodium | 13 | $104 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Miami
- Michael WeitzMiami$658K
- Joseph la ContiMiami$345K
- Robert HoffmanMiami$241K
- Christopher MesaMiami$198K
- George MunozMiami$147K
- Santiago de SoloMiami$98K
- Carlos LozadaMiami$97K
- Reuven BrombergMiami$78K
- Jeffrey RitterMiami$39K
- Alvin WellsDestin$2.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.